✦ LIBER ✦

Mitomycin C cross-resistance induced by Adriamycin in human ovarian cancer cells in vitro

✍ Scribed by Kimio Mizuno; Yoshihito Furuhashi; Osamu Maeda; Mitsumasa Iwata; Toshiya Misawa; Michiyasu Kawai; Takeo Kano; Yutaka Tomoda

Publisher: Springer
Year: 1990
Tongue: English
Weight: 725 KB
Volume: 26
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf02897288

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanism of cross-resistance to cisplat

Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line

✍ Shivendra V. Singh; Bing H. Xu; Jitesh P. Jani; Erling O. Emerson; Mary G. Backe 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 730 KB

This study was undertaken to elucidate the mechanism@) of cross-resistance to cisplatin (CDDP) in a mitomycin C (MMC)resistant human bladder cancer cell line, J82/MMC. The J82/ MMC cell line displayed 2-to 3-fold cross-resistance to CDDP and carboplatin when compared to the parental )82/WT cells. Dr

Progesterone induces Apoptosis in TRAIL-

Progesterone induces Apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression

✍ Viqar Syed; Kasturi Mukherjee; Sonia Godoy-Tundidor; Shuk-Mei Ho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 1 views

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) holds great potential as an anticancer drug, since it induces selective cell death in cancer cells but not in normal ones. However, cancer cells often acquire resistance to TRAIL, which hinders its clinical efficacy. We previously demon

Apoptosis induced by progesterone in hum

Apoptosis induced by progesterone in human ovarian cancer cell line SNU-840

✍ Sunhee Yu; Minhyung Lee; Seungjin Shin; Jong-sang Park 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB 👁 1 views

## Abstract Progesterone has been used as an ingredient of anticancer drug for patients with ovarian carcinoma. However, the mechanism of anticancer effects by progesterone has not been understood. In this study, the effects of progesterone on ovarian cancer cells, SNU‐840, were investigated. After

Modulation of induced resistance to adri

Modulation of induced resistance to adriamycin in two human breast cancer cell lines with tamoxifen or perhexiline maleate

✍ Brenda J. Foster; Karen R. Grotzinger; Wilma M. McKoy; Lawrence V. Rubinstein; T 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 602 KB

The clinical utility of adriamycin in the treatment of patients with metastatic breast cancer is often-limited by the development of drug resistance. It has been recognized that in addition to the development of primary resistance against adriamycin, malignant cells can simultaneously develop cross-

Induction of MRP5 and SMRP mRNA by adria

Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin

✍ Makoto Yoshida; Toshihiro Suzuki; Takefumi Komiya; Erina Hatashita; Kazuto Nishi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 156 KB

Influence of docosahexaenoic acid in vit

Influence of docosahexaenoic acid in vitro on intracellular adriamycin concentration in lymphocytes and human adriamycin-sensitive and -resistant small-cell lung cancer cell lines, and on cytotoxicity in the tumor cell lines

✍ J. G. Zulstra; E. G. E. De Vries; F. A. J. Muskiet; L. A. Martini; H. Timmer-Bos 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 619 KB

An increase in the therapeutic effects of cancer chemotherapeutic agents and circumvention of drug resistance in cancer cells might result from an increase in the intracellular drug level. Alteration of the lipid domain of the cell membrane can result in a higher intracellular drug level. This alter